References
- Yanovski SZ, Yankovski JA. Obesity. N Engl J Med 2002; 346(8): 591–602
- World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization, 2000; WHO Tech Rep Ser 894
- Block JP, DeSalvo KB, Fisher WP. Are physicians equipped to address the obesity epidemic? Knowledge and attitudes of internal medicine residents. Prev Med 2003; 36(6): 669–75
- National Center for Health Statistics, Centers for Disease Control and Prevention. Prevalence of overweight and obesity among adults: United States, 1999–2000. Available at: http://www.cdc.gov/nchs/products/pubs/hestats/obese/obse99.ht. Accessed Nov 24, 2003
- Peters JC, Wyatt HR, Donahoo WT, et al. From instinct to intellect: the challenge of maintaining healthy weight in the modern world. Obes Rev 2002; 3(2): 69–74
- Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National Institutes of Health. Obes Res 1998; 6(Suppl 2): 51–209S [Erratum, Obes Res 1998;6(6): 464]
- Hill JO, Wyatt HR, Reed GW, et al. Obesity and the environment: Where do we go from here? Science 2003; 299(5068): 853–5
- Comuzzie AG, Allison DB. The search for human obesity genes. Science 1998; 280(5368): 1374–7
- Levine JA, Eberhardt NL, Jensen MD. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 1999; 283(5399): 212–4
- Grizzard T. Undertreatment of obesity. JAMA 2002; 288(17): 2177
- Allison DB, Saunders SE. Obesity in North America: an overview. Med Clin North Am 2000; 84(2): 305–32
- The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. Rockville, Md: US Dept of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, North American Association for the Study of Obesity, 2000; NIH publication 00–4084
- Brownell KD. Diet, exercise and behavioural intervention: the nonpharmacological approach. Eur J Clin Invest 1998; 28(Suppl 2): 19–21; discussion 22
- Eckel RH. Obesity: a disease or a physiologic adaptation for survival? In: Eckel RH, ed. Obesity mechanisms and clinical management. Philadelphia: Lippincott Williams & Wilkins, 2003: 3–30
- Bray GA. Drug treatment of overweight. In: Bray GA, ed. Contemporary diagnosis and management of obesity. 2nd ed. Newtown, Pa: Handbooks in Healthcare, 2003: 263–300
- James WP, Astrup A, Finer N, et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356(9248): 2119–25
- Foster GD, Wadden TA, Vogt RA, et al. What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol 1997; 65(1): 79–85
- Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346(6): 393–403
- Foster GD. Goals and strategies to improve behavior-change effectives. In: Bessesen DH, Kushner R, eds. Evaluation and management of obesity. Philadelphia: Hanley & Belfus, 2002: 29–32
- Wadden TA, Berkowitz RI, Sarwer DB, et al. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med 2001; 161(2): 218–27
- Wadden TA, Foster GD. Behavioral treatment of obesity. Med Clin North Am 2000; 84(2): 441–61